Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia

This study has been completed.
Stanley Medical Research Institute
Information provided by (Responsible Party):
Xiang Yang Zhang, Beijing HuiLongGuan Hospital Identifier:
First received: July 7, 2011
Last updated: July 10, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2011
  Primary Completion Date: April 2011 (Final data collection date for primary outcome measure)